SCHEMBL17486148

SCHEMBL17486148

c1ccc(-n2c3ccccc3c3c(-c4ccccn4)cccc32)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.49
▸ L3MBTL1 Q9Y468 3/20 0.49
▸ ATM Q13315 1/20 0.49
▸ MAPK14 Q16539 1/20 0.46
▸ BRD4 O60885 2/20 0.39
▸ GRM5 P41594 1/20 0.38
▸ LMNA P02545 2/20 0.37
▸ CCR1 P32246 2/20 0.37
▸ CCR5 P51681 2/20 0.37
▸ CCR8 P51685 2/20 0.37
▸ HIF1A Q16665 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ METAP1 P53582 1/20 0.37
▸ BLM P54132 1/20 0.37
▸ DOHH Q9BU89 1/20 0.37
▸ P4HTM Q9NXG6 1/20 0.37
▸ PRKCI P41743 1/20 0.37
▸ TP53 P04637 2/20 0.37
▸ MAPK1 P28482 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8739886 0.93 MAPK14 (0.45) KDM4EL3MBTL1ATMMAPK14BRD4
SCHEMBL25140476 0.92 MAPK14 (0.43) KDM4EL3MBTL1ATMMAPK14BRD4
SCHEMBL17252445 0.85 L3MBTL1 (0.52) KDM4EL3MBTL1ATMMAPK14BRD4
SCHEMBL29783135 0.84 KDM4E (0.50) KDM4EL3MBTL1ATMMAPK14BRD4
SCHEMBL28418744 0.84 KDM4E (0.50) KDM4EL3MBTL1ATMMAPK14BRD4
SCHEMBL11998209 0.83 KDM4E (0.41) KDM4EL3MBTL1ATMMAPK14GRM5
SCHEMBL11998218 0.82 L3MBTL1 (0.65) KDM4EL3MBTL1ATMPOLBMAPK1
SCHEMBL17349366 0.81 KDM4E (0.47) KDM4EL3MBTL1ATMHIF1ACYP1A2
SCHEMBL23805821 0.81 KDM4E (0.47) KDM4EL3MBTL1ATMLMNACCR1
SCHEMBL17349052 0.81 KDM4E (0.47) KDM4EL3MBTL1ATMALDH1A1LOXL3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174890-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-03-13 — — EP disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 — — US disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 — — US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 — — US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 — — US disclosed
WO-2016015815-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-02-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250353-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 KDM4E 3816/4885L3MBTL1 3160/4885ATM 3760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback